| Identification | Back Directory | [Name]
L-chiro-Inositol, 4-amino-1,4-dideoxy-3-O-(2,6-diamino-2,3,4,6,7-penta deoxy-beta-L-lyxo-heptopyranosyl)-6-O-methyl-1-(2-(formimidoylamino)-N -methylacetamido)-, sulfate (1:2), hydrate | [CAS]
73245-91-7 | [Synonyms]
SF-2052 sulfate
Dactimicin sulfate
Antibiotic SF 2052 sulfate
L-chiro-Inositol, 4-amino-1,4-dideoxy-3-O-(2,6-diamino-2,3,4,6,7-penta deoxy-beta-L-lyxo-heptopyranosyl)-6-O-methyl-1-(2-(formimidoylamino)-N -methylacetamido)-, sulfate (1:2), hydrate | [Molecular Formula]
C18H36N6O6.H2O.2H2O4S | [MDL Number]
MFCD01939663 | [MOL File]
73245-91-7.mol | [Molecular Weight]
646.689 |
| Safety Data | Back Directory | [Safety Profile]
A poison by
intravenous and intramuscular route.
Moderately toxic by subcutaneous route.
When heated to decomposition it emits
toxic vapors of NOx and SOx
|
| Hazard Information | Back Directory | [Uses]
Dactimicin sulfate (SF-2052 sulfate) is an antibiotic produced by Dactylosporangium matsuzakiense and belongs to the fortimicin antibiotic family. Dactimicin sulfate is an aminoglycoside antibiotic containing a carboximido group and inhibits protein synthesis by binding to the 30S ribosomal subunit of bacteria. Dactimicin sulfate can be used in research on infections caused by sensitive bacteria[1]. | [IC 50]
Aminoglycoside | [References]
[1] ATSUMI K, et al. Synthesis of dactimicin[J]. The Journal of Antibiotics, 1982, 35(1): 90-91. DOI:10.7164/antibiotics.35.90 |
|
|